Home|Journals|Articles by Year|Audio Abstracts

Original Article

Characterization of ethyl acetate and methanol extracts of Commiphora myrrha and evaluating in-vitro anti-diabetic and anti-obesity activities.

Heba Abdel Hady,Eman Ahmed El Wakil,Eman Abdalla Morsi.

Cited by 8 Articles

Diabetes mellitus is a clinical syndrome characterized by hyperglycemia. Reduction of gastrointestinal glucose absorption through the inhibition of carbohydrate digesting enzymes is one of in-vitro anti-diabetic therapeutic approach. This study aimed to evaluate the in-vitro anti-diabetic and anti-obesity activities of ethyl acetate and methanol extracts of Commiphora myrrha oleo-gum as well as identification of the bioactive compounds. Commiphora myrrha was extracted with methanol and ethyl acetate. The two extracts were used to evaluate their α-amylase, α-glucosidase and pancreatic lipase inhibitory activities. Identification of the bioactive compounds in ethyl acetate was analysed by GC-MS gas chromatograph. The results showed that the ethyl acetate extract had a stronger inhibitory activity on α-amylase (IC50=54.60µg/ml) and α-glucosidase (IC50=58.7µg/ml) than methanol extract on α-amylase (IC50=124.01µg/ml) and α-glucosidase (IC50= 191.2µg/ml). Also, ethyl acetate extract had a promising inhibitory effect on pancreatic lipase (IC50= 107.8µg/ml) than methanol extract (IC50= 498.1µg/ml). Gas chromatography - mass spectrometry analysis of the ethyl acetate extract identified 31 compounds. Among them nobiletin (50.26%), metaproterenol (orciprenaline) (14.99%), morantel (8.86%) and tricetin (3.38%) were the main compounds. These findings proved that Commiphora myrrha has anti-diabetic and anti-obesity inhibition activity may be due to the bioactive compounds with interesting medicinal properties.

Key words: GC-MS gas chromatograph, α-amylase, α-glucosidase, Pancreatic lipase, Flavonoids.

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.